Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(5 sites)
Germany
Praxisklinik Ulmenhof, Hamburg Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta (CBNI), Milan Norway
St Olavs Hospital, Trondheim Spain
Department of Neurology, University Clinic Hospital. Catholic University of Valencia, Valencia United Kingdom
National Hospital of Neurology and Neurosurgery, University College of London, London Age range
18 Years – 85 Years
Last updated November 2024